Advertisements



Iovance Biotherapeutics reports results from FDA end of Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Cerus reports results of SPARC Phase 3 study at EHA meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Loxo Oncology Reports First Quarter 2018 Financial Results

- LOXO-292 Phase 1 Oral Presentation Upcoming at 2018 ASCO Annual Meeting - - LOXO-292 Preclinical and Cl.....»»

Category: earningsSource: benzingaMay 8th, 2018

AMREP Reports Second Quarter Fiscal 2019 Results

PLYMOUTH MEETING, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $55,000, or $0.00 per share, for its 2019 second fiscal q.....»»

Category: earningsSource: benzingaDec 11th, 2018

Alkermes reports positive results in trial of schizophrenia treatment that reduces weight gain

Alkermes Plc announced positive results Thursday for a trial of its ALKS 3832 treatment for schizophrenia. The Phase 3 tr.....»»

Category: topSource: marketwatchNov 29th, 2018

InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results

Completion of patient recruitment in phase IIb trial in Hidradenitis Suppurativa First pa.....»»

Category: earningsSource: benzingaNov 21st, 2018

Qudian Inc. Reports Third Quarter 2018 Unaudited Financial Results and Issues Notice of Annual General Meeting

Qudian Inc. Reports Third Quarter 2018 Unaudited Financial Results and Issues Notice of Annual General Meeting.....»»

Category: earningsSource: benzingaNov 21st, 2018

Denali Therapeutics reports "positive" results from Phase 1 DNL747 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Atara Biotherapeutics announces publication of Phase 1 ATA190 results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Leju Reports Third Quarter 2018 Results and Issues Notice of Annual General Meeting

Leju Reports Third Quarter 2018 Results and Issues Notice of Annual General Meeting.....»»

Category: dealsSource: nytNov 19th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP and Reports Third Quarter 2018 Financial Results

Phase 2/.....»»

Category: earningsSource: benzingaNov 13th, 2018

ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update

Phase 3 trial for eryaspase in second line pancreatic cancer enrolling patients Phase 2 trial in triple-negative breast cancer to enroll patients by year end Cash position of €146.9 million ($170 million) as of September 30, 2018 LYON, France and CAM.....»»

Category: earningsSource: benzingaNov 12th, 2018

Concert Pharmaceuticals reports "positive" CTP-543 results in Phase 2a trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Asterias Biotherapeutics Reports Third Quarter Results

Clinical Programs Continue to ProgressRecent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating ExpensesRecently Announced Definitive Merger Agreement with BioTime Creates Leading Cel.....»»

Category: earningsSource: benzingaNov 9th, 2018

Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results

-- Presented Updated Data from Phase 2 Basket Studies in Bardet-Biedl Syndrome (BBS) and Alström Syndrome at the 57th.....»»

Category: earningsSource: benzingaNov 9th, 2018

Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress

OV101 in Angelman syndrome: Plan to meet with U.S. FDA in the fourth quarter of 2018 to review Phase 2 STARS results and discuss next steps for program OV935/TAK-935 in rare developmental and epileptic encephalopathies: 12-week data from P.....»»

Category: earningsSource: benzingaNov 8th, 2018

Interim Report January - September 2018

STOCKHOLM, Nov. 8, 2018 /PRNewswire/ -- BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients. AbbV.....»»

Category: earningsSource: benzingaNov 8th, 2018

Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results

WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the thi.....»»

Category: earningsSource: benzingaNov 7th, 2018

Protalix BioTherapeutics Reports 2018 Third Quarter Results and Provides Corporate Update

CARMIEL, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE:PLX, TAS.....»»

Category: earningsSource: benzingaNov 7th, 2018

Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q3 2018 Results - Earnings Call Transcript

Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 6th, 2018